FDA Drug Application (021361) for XIFAXAN by SALIX PHARMS

Back to FDA Applications sponsored by SALIX PHARMS

Application Number021361
Product Number001
FormTABLET;ORAL
Dosage200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXIFAXAN
Active IngredientRIFAXIMIN



Back to FDA Applications sponsored by SALIX PHARMS